Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Sunnybrook Health Sciences Centre
Sponsor:
Collaborators:
St. Michael's Hospital, Toronto
Allergan
Information provided by (Responsible Party):
Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT01701518
First received: October 3, 2012
Last updated: January 20, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)